Neoadjuvant Treatment of Locoregional Metastases in Malignant Melanoma (AJCC Stage IIIB/C) With Multiferon: a Phase IIa DeCOG Trial.

Trial Profile

Neoadjuvant Treatment of Locoregional Metastases in Malignant Melanoma (AJCC Stage IIIB/C) With Multiferon: a Phase IIa DeCOG Trial.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Nov 2014

At a glance

  • Drugs Interferon alpha (Primary)
  • Indications Malignant melanoma
  • Focus Biomarker; Therapeutic Use
  • Acronyms NAM
  • Most Recent Events

    • 30 Jun 2012 Company added in the association field as reported by EudraCT.
    • 09 May 2012 New source identified and integrated (German Clinical Trials Register; DRKS00003619).
    • 22 Feb 2012 New source identified and integrated (EudraCT2010-022103-21; European Clinical Trials Database).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top